Encino, California Clinical Trials

A listing of Encino, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

bethesda assay
factor ix
haemophilia a
hemophilia
fitusiran
Investigational Site Number 8400002
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …

Investigational Site Number :8400002
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +22 other locations
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Cedars-Sinai Medical Center
 (10.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Clinical Testing of Beverly Hills
 (1.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

hematologic malignancy
allogeneic transplantation
cancer
investigational treatment
UCLA
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness and Parental Substance Use

The goal of this study is to pilot an adapted family resilience program among families with a recent history of homelessness and parental substance use disorders in Los Angeles County and to assess for feasibility and acceptability. The investigators have adapted a family resilience program called Families Overcoming Under Stress …

UCLA
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

aortic valve replacement
shortness of breath
regurgitation
fatigue
Cedars Sinai Medical Center
 (10.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

combined modality therapy
docetaxel
prostatic neoplasms, castration-resistant
combination therapy
antiandrogens
The University of California, Los Angeles
 (1.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

The main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical management plan in Veterans. In this study, the management plan prior to and after 18F-DCFPyL PET/CT will be recorded by specific questionnaires and corresponding …

positron emission tomography
external beam radiation therapy
pet/ct scan
salvage therapy
definitive treatment
VA Greater Los Angeles Healthcare System
 (7.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

This is a phase 1/2, multi-center study with an open-label, dose escalation phase followed by a single-arm expansion phase to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 alone and in combination with ERBITUX (cetuximab) in adults with recurrent and/or metastatic solid tumors.

head and neck cancer
metastasis
serum pregnancy test
metastatic squamous cell carcinoma
head and neck carcinoma
The Angeles Clinic and Research Institute
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations